These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2211445

  • 21. The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
    Wise R, Andrews JM, Brenwald N.
    J Antimicrob Chemother; 1993 Jan; 31(1):73-80. PubMed ID: 8383104
    [Abstract] [Full Text] [Related]

  • 22. BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
    Gordon KA, Pfaller MA, Jones RN, SENTRY Participants Group.
    J Antimicrob Chemother; 2002 May; 49(5):851-5. PubMed ID: 12003983
    [Abstract] [Full Text] [Related]

  • 23. The in-vitro activity of PD127,391, a new quinolone.
    King A, Boothman C, Phillips I.
    J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
    [Abstract] [Full Text] [Related]

  • 24. Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.
    Qadri SM, Ueno Y, Postle G, Tullo D, San Pedro J.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):372-7. PubMed ID: 8394816
    [Abstract] [Full Text] [Related]

  • 25. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
    Bauernfeind A.
    J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
    [Abstract] [Full Text] [Related]

  • 26. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
    Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR.
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
    [Abstract] [Full Text] [Related]

  • 27. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.
    Chemotherapy; 1998 Aug; 44(2):85-93. PubMed ID: 9551237
    [Abstract] [Full Text] [Related]

  • 28. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
    Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
    [Abstract] [Full Text] [Related]

  • 29. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL, Fuchs PC, Brown SD.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [Abstract] [Full Text] [Related]

  • 30. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Jun; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates.
    Gönüllü N, Aktaş Z, Salcioglu M, Bal C, Ang O.
    Clin Microbiol Infect; 2001 Sep; 7(9):499-503. PubMed ID: 11678934
    [Abstract] [Full Text] [Related]

  • 32. In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1986 Aug; 18(2):159-62. PubMed ID: 3093447
    [Abstract] [Full Text] [Related]

  • 33. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 34. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates.
    Giamarellou H, Voutsinas D, Xirouchaki E.
    J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554
    [Abstract] [Full Text] [Related]

  • 35. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX, Neu HC.
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Chemotherapy; 1992 Feb; 38(2):99-106. PubMed ID: 1317282
    [Abstract] [Full Text] [Related]

  • 38. In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.
    Rolston KV, Vaziri I, Frisbee-Hume S, Streeter H, LeBlanc B.
    Chemotherapy; 2004 Nov; 50(5):214-20. PubMed ID: 15523180
    [Abstract] [Full Text] [Related]

  • 39. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
    Matsuzaki K, Watabe E, Yoshimori K, Shikano M, Sato Y, Hasegawa M, Kobayashi I.
    Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Dec; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.